Mirae Asset Global Investments’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Sell
1,708
-282
-14% -$19.4K ﹤0.01% 1196
2026
Q1
$127K Buy
1,990
+156
+9% +$10.8K ﹤0.01% 1143
2025
Q4
$146K Buy
1,834
+490
+36% +$41.4K ﹤0.01% 1200
2025
Q3
$88.8K Buy
1,344
+6
+0.4% +$357 ﹤0.01% 1239
2025
Q2
$70.9K Buy
1,338
+181
+16% +$8.5K ﹤0.01% 1200
2025
Q1
$60.6K Buy
1,157
+165
+17% +$9.18K ﹤0.01% 1206
2024
Q4
$63.6K Sell
992
-83
-8% -$4.8K ﹤0.01% 1232
2024
Q3
$53.8K Buy
1,075
+337
+46% +$15.8K ﹤0.01% 1291
2024
Q2
$32.7K Buy
+738
New +$25.1K ﹤0.01% 1317

Other funds holding IRON

Mirae Asset Global Investments's IRON Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Disc Medicine (IRON) stake by 14% in Q2 2026, selling an estimated $19.4K and leaving 1,708 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.

Mirae Asset Global Investments first reported a position in IRON in Q2 2024 and has held it in 9 quarters since. The position peaked at $146K in Q4 2025. 58 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Mirae Asset Global Investments held 1,708 shares of Disc Medicine worth $125K as of Q2 2026.
  • Mirae Asset Global Investments sold 282 Disc Medicine shares in Q2 2026, an estimated $19.4K.
  • Disc Medicine made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1196 holding.
  • Mirae Asset Global Investments first reported a position in Disc Medicine in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Disc Medicine position peaked at $146K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.